Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA World Funds - Framlington Health

+ Add to Watchlist

AFRHLEE:LX

243.86 EUR 1.79 0.74%

As of 00:59:30 ET on 03/02/2015.

Snapshot for AXA World Funds - Framlington Health (AFRHLEE)

Year To Date: +15.51% 3-Month: +17.41% 3-Year: +30.66% 52-Week Range: 149.80 - 242.81
1-Month: +5.48% 1-Year: +45.95% 5-Year: +22.28% Beta vs LUXXX: 0.64

Mutual Fund Chart for AFRHLEE

No chart data available.
  • AFRHLEE:LX 243.86
  • 1M
  • 1Y
Interactive AFRHLEE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for AFRHLEE

AXA World Funds - Framlington Health is a SICAV incorporated in Luxembourg. The Fund will invest permanently at least two thirds of the total assets in equities and equities related instruments issued by companies engaged in healthcare and medical services and product worldwide.

Inception Date: 01-12-2007 Telephone: 352-44-24-24-1
Managers: GEMMA GAME / BRUNO GRANDSARD
Web Site: www.axa-im.lu

Fundamentals for AFRHLEE

NAV (on 2015-03-02) 243.86
Assets (M) (on 2015-02-27) 105.02
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for AFRHLEE

No dividends reported

Fees & Expenses for AFRHLEE

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 2.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for AFRHLEE

Filing Date: 01/30/2015
Name Position Value % of Total
Roche Holding AG 19,216 5,192,215 5.643%
Gilead Sciences Inc 45,893 4,810,963 5.229%
Novartis AG 44,510 4,361,259 4.740%
Amgen Inc 17,007 2,589,486 2.814%
Medtronic PLC 34,480 2,461,872 2.676%
Celgene Corp 20,276 2,416,088 2.626%
UnitedHealth Group Inc 21,228 2,255,475 2.451%
AbbVie Inc 36,433 2,198,732 2.390%
Biogen Idec Inc 5,513 2,145,439 2.332%
Express Scripts Holding Co 25,312 2,042,932 2.220%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil